Additional Purchase of Cryptoassets and Impairment Loss on Cryptoassets Held
Remixpoint,inc.
Bitcoin, Ethereum, Solana, Ripple, Dogecoin
The Company measures its cryptoasset holdings at fair value on a quarterly basis. The reason for the decline in cryptoasset prices and the reason for the additional purchase have not been disclosed.
The Company expects to recognize an impairment loss on cryptoassets of ¥5,893 million for the fiscal year ended March 2026. This is scheduled to be reflected in the consolidated statement of income as a decrease in net sales. The impairment gain or loss for the fiscal year ending March 2027 is ¥3,496,221,930.
The fiscal year ended March 2026 and the fiscal year ending March 2027
Not disclosed. The effect is scheduled to be reflected as a decrease in net sales in the consolidated financial results summary for the fiscal year ended March 2026, prepared in accordance with Japanese GAAP.
If the Company’s consolidated results are materially affected in the future, it will make a timely disclosure. The impairment gain or loss of ¥3,496,221,930 in the holdings described above will be fully reflected in the results for the fiscal year ending March 2027.
The Company plans to release the consolidated financial results summary for the fiscal year ended March 2026, prepared in accordance with Japanese GAAP, on 15 May 2026. If the Company’s consolidated results are materially affected, it will make a timely disclosure.
| Item | Details |
|---|---|
| Event name | Additional Purchase of Cryptoassets and Impairment Loss on Cryptoassets Held |
| Date of occurrence | 22 April 2026 (Board of Directors resolution and execution of the additional purchase), and as of 31 March 2026 (impairment loss on cryptoassets held) |
| Subject Entity | Remixpoint,inc. |
| Target Locations / Products | Bitcoin, Ethereum, Solana, Ripple, Dogecoin |
| Cause | The Company measures its cryptoasset holdings at fair value on a quarterly basis. The reason for the decline in cryptoasset prices and the reason for the additional purchase have not been disclosed. |
| Amount of Impact on Business Performance | The Company expects to recognize an impairment loss on cryptoassets of ¥5,893 million for the fiscal year ended March 2026. This is scheduled to be reflected in the consolidated statement of income as a decrease in net sales. The impairment gain or loss for the fiscal year ending March 2027 is ¥3,496,221,930. |
| Accounting period in which recognized | The fiscal year ended March 2026 and the fiscal year ending March 2027 |
| Impact on Earnings Forecast | Not disclosed. The effect is scheduled to be reflected as a decrease in net sales in the consolidated financial results summary for the fiscal year ended March 2026, prepared in accordance with Japanese GAAP. |
| Outlook | If the Company’s consolidated results are materially affected in the future, it will make a timely disclosure. The impairment gain or loss of ¥3,496,221,930 in the holdings described above will be fully reflected in the results for the fiscal year ending March 2027. |
| Planned follow-up disclosure | The Company plans to release the consolidated financial results summary for the fiscal year ended March 2026, prepared in accordance with Japanese GAAP, on 15 May 2026. If the Company’s consolidated results are materially affected, it will make a timely disclosure. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company explains that it recognizes the impairment loss because it measures its cryptoasset holdings at fair value on a quarterly basis. No reason for the additional purchase is provided.